Direct Flow Medical, Inc. Announces IDE Approval for U.S. Pivotal Trial

Direct Flow Medical®, Inc., a transcatheter heart valve company focused on innovation for improved patient outcomes, has received Investigational Device Exemption approval from the Food and Drug Administration to initiate the pivotal phase of the SALUS Trial.



from Content Keyword RSS http://ift.tt/1mXWbHf

via IFTTT